Rising respiratory diseases are Propelling the Growth of the Respiratory Endotherapy Devices Market in the APAC Region!

Author: Himanshu Patni

November 18, 2023

The Asia Pacific Respiratory Endotherapy Devices market is a significant contributor to the global Respiratory Endotherapy Devices market, which is expected to grow significantly during the forecast period. The increasing incidences of respiratory diseases, along with the increasing population in the region are among the important driving factors for the Respiratory Endotherapy Devices market in the region. For Instance, as per the data of WHO, lung cancer is the leading type of cancer among the Asian population and about 1.3 Million newly diagnosed cases of lung cancer was observed during the year 2020.

Access sample report (including graphs, charts, and figures) https://univdatos.com/get-a-free-sample-form-php/?product_id=45765

Further, Asia-Pacific respiratory endotherapy market was valued USD XX Million in year 2022 and is expected to grow with a CAGR of 7.3% during the forecasted year (2023-2030).. The growing population and rising respiratory diseases among them are the major reason for the market growth of Respiratory Endotherapy Devices in the Asia-Pacific.

FIG. 1 APAC Respiratory Endotherapy Devices Market Revenue (2020-2030)- USD Mn

Based on the device, the market is segmented into diagnostic devices and therapeutic devices. The therapeutic devices category dominated the market in 2022. Respiratory endotherapy is recommended when there is a need of aspirating thick section that are causing atelectasis of lungs, to remove foreign bodies from the lungs and reduce or remove tumors in the trachea or bronchi. Rising cases of pulmonary disorders, and launch of technologically advanced bronchoscopes are driving the market of therapeutic devices segment.

On the basis of end-users, the market is categorized into Hospitals, diagnostic centers, and ambulatory surgical centers. Among these, the hospital’s category held a significant share of the market in 2022. This is mainly due to the high volume of respiratory endotherapy procedures performed in hospitals, as well as the availability of advanced medical equipment and expertise in this setting. Further, increasing demand for minimally invasive procedures and the growing availability of advanced medical equipment and technologies are also contributing to the growth of the market

For a detailed analysis of Global Respiratory Endotherapy Devices Market browse throughhttps://univdatos.com/report/respiratory-endotherapy-devices-market/

Global Respiratory Endotherapy Devices Market Segmentation

Market Insight, by Devices

· Diagnostic Devices

o Trans Bronchial Aspiration

o Biopsy forceps

o Cytology Brushes

o Others

· Therapeutic Devices

o Bronchoscope

o Bronchial Thermoplasty Systems

o Pulmonary Balloon Dilation Catheter

o Stents

o Others

Market Insight, by End User

· Hospitals

· Diagnostic Centers

· Ambulatory Surgical Centers

Market Insight, by Region

· North America

o U.S.

o Canada

o Rest of North America

· Europe

o Germany

o UK

o France

o Italy

o Spain

o Rest of Europe

· APAC

o China

o Japan

o India

o Rest of APAC

· Rest of the World

Top Company Profiles

· Fujifilm Holdings Corporation

· Medtronic

· Johnson & Johnson

· Smith & Nephew Plc.

· Stryker corporation

· Olympus

· Hoya corporation

· Steris Healthcare

· Conmed

· Boston Scientific corporation

Get a Callback


Related News